Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN DIEGO, March 20, 2024 (GLOBE NEWSWIRE) -- As more companies are leveraging the powerful capabilities of the QCI Enterprise Platform, QCI proudly introduces QCI College – a unique initiative that...
-
Easton, Md., March 20, 2024 (GLOBE NEWSWIRE) -- Qlarant is proud to announce the addition of Mr. Michael O. Cooke as Chief Strategy and Growth Officer (CGSO). This is a new position for the...
-
MOUNT LAUREL, N.J. and MUMBAI, India, March 20, 2024 (GLOBE NEWSWIRE) -- Hill International, Inc., delivering the infrastructure of change, announced today the appointment of Kshitish V. Nadgauda as...
-
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for...
-
EDEN PRAIRIE, MN, March 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
-
Kenmare Resources plc(“Kenmare” or “the Company” or “the Group”) 20 March 2024 2023 PRELIMINARY RESULTS Kenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of...
-
LONDON, March 19, 2024 (GLOBE NEWSWIRE) -- The global market for agricultural robot has seen significant growth in recent years, as indicated by the latest report titled " Agricultural Robot Global...
-
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BioVie Inc. (“BioVie” or the “Company”)...
-
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company...
-
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central...